List of Tables
Table 1. Global Veterinary Lyme Disease Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Veterinary Lyme Disease Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Veterinary Lyme Disease Vaccine Market Competitive Situation by Manufacturers in 2025
Table 4. Global Veterinary Lyme Disease Vaccine Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Veterinary Lyme Disease Vaccine Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Veterinary Lyme Disease Vaccine Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Veterinary Lyme Disease Vaccine Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Veterinary Lyme Disease Vaccine Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Veterinary Lyme Disease Vaccine, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Veterinary Lyme Disease Vaccine, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Veterinary Lyme Disease Vaccine, Product Types and Applications
Table 12. Global Key Manufacturers of Veterinary Lyme Disease Vaccine, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Lyme Disease Vaccine Companies by Tier (Tier 1, Tier 2, Tier 3), based on Veterinary Lyme Disease Vaccine Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Veterinary Lyme Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Veterinary Lyme Disease Vaccine Sales by Region (K Dose), 2021–2026
Table 18. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region (2021–2026)
Table 19. Global Veterinary Lyme Disease Vaccine Sales by Region (K Dose), 2027–2032
Table 20. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region (2027–2032)
Table 21. Global Veterinary Lyme Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 22. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2021–2026)
Table 23. Global Veterinary Lyme Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 24. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2027–2032)
Table 25. North America Veterinary Lyme Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2021–2026
Table 27. North America Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2027–2032
Table 28. North America Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 29. North America Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Veterinary Lyme Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2021–2026
Table 32. Europe Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2027–2032
Table 33. Europe Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Veterinary Lyme Disease Vaccine Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Veterinary Lyme Disease Vaccine Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Veterinary Lyme Disease Vaccine Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Veterinary Lyme Disease Vaccine Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Veterinary Lyme Disease Vaccine Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Veterinary Lyme Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2021–2026
Table 42. Latin America Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2027–2032
Table 43. Latin America Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Veterinary Lyme Disease Vaccine Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Veterinary Lyme Disease Vaccine Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Veterinary Lyme Disease Vaccine Revenue by Country (US$ Million), 2027–2032
Table 50. Global Veterinary Lyme Disease Vaccine Sales (K Dose) by Type (2021–2026)
Table 51. Global Veterinary Lyme Disease Vaccine Sales (K Dose) by Type (2027–2032)
Table 52. Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2021–2026)
Table 53. Global Veterinary Lyme Disease Vaccine Sales Market Share by Type (2027–2032)
Table 54. Global Veterinary Lyme Disease Vaccine Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Veterinary Lyme Disease Vaccine Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2021–2026)
Table 57. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Type (2027–2032)
Table 58. Global Veterinary Lyme Disease Vaccine Price (US$/Dose) by Type (2021–2026)
Table 59. Global Veterinary Lyme Disease Vaccine Price (US$/Dose) by Type (2027–2032)
Table 60. Global Veterinary Lyme Disease Vaccine Sales (K Dose) by Application (2021–2026)
Table 61. Global Veterinary Lyme Disease Vaccine Sales (K Dose) by Application (2027–2032)
Table 62. Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2021–2026)
Table 63. Global Veterinary Lyme Disease Vaccine Sales Market Share by Application (2027–2032)
Table 64. Global Veterinary Lyme Disease Vaccine Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Veterinary Lyme Disease Vaccine Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2021–2026)
Table 67. Global Veterinary Lyme Disease Vaccine Revenue Market Share by Application (2027–2032)
Table 68. Global Veterinary Lyme Disease Vaccine Price (US$/Dose) by Application (2021–2026)
Table 69. Global Veterinary Lyme Disease Vaccine Price (US$/Dose) by Application (2027–2032)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Zoetis Company Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Veterinary Lyme Disease Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Zoetis Veterinary Lyme Disease Vaccine Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Veterinary Lyme Disease Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Merck Veterinary Lyme Disease Vaccine Product
Table 84. Merck Recent Developments/Updates
Table 85. Bioveta Company Information
Table 86. Bioveta Description and Business Overview
Table 87. Bioveta Veterinary Lyme Disease Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Bioveta Veterinary Lyme Disease Vaccine Product
Table 89. Bioveta Recent Developments/Updates
Table 90. Elanco Company Information
Table 91. Elanco Description and Business Overview
Table 92. Elanco Veterinary Lyme Disease Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Elanco Veterinary Lyme Disease Vaccine Product
Table 94. Elanco Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Veterinary Lyme Disease Vaccine Distributors List
Table 98. Veterinary Lyme Disease Vaccine Customers List
Table 99. Veterinary Lyme Disease Vaccine Market Trends
Table 100. Veterinary Lyme Disease Vaccine Market Drivers
Table 101. Veterinary Lyme Disease Vaccine Market Challenges
Table 102. Veterinary Lyme Disease Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Veterinary Lyme Disease Vaccine
Figure 2. Global Veterinary Lyme Disease Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Veterinary Lyme Disease Vaccine Market Share by Type: 2025 & 2032
Figure 4. Monovalent Vaccines Product Picture
Figure 5. Combination Vaccines Product Picture
Figure 6. Global Veterinary Lyme Disease Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Veterinary Lyme Disease Vaccine Market Share by Application: 2025 & 2032
Figure 8. Canine
Figure 9. Feline
Figure 10. Others
Figure 11. Global Veterinary Lyme Disease Vaccine Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Veterinary Lyme Disease Vaccine Market Size (US$ Million), 2021–2032
Figure 13. Global Veterinary Lyme Disease Vaccine Sales (K Dose), 2021–2032
Figure 14. Global Veterinary Lyme Disease Vaccine Average Price (US$/Dose), 2021–2032
Figure 15. Veterinary Lyme Disease Vaccine Report Years Considered
Figure 16. Veterinary Lyme Disease Vaccine Sales Share by Manufacturers in 2025
Figure 17. Global Veterinary Lyme Disease Vaccine Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Veterinary Lyme Disease Vaccine Players: Market Share by Revenue in Veterinary Lyme Disease Vaccine in 2025
Figure 19. Veterinary Lyme Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Veterinary Lyme Disease Vaccine Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 22. North America Veterinary Lyme Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 23. United States Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 26. Europe Veterinary Lyme Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 27. Germany Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Veterinary Lyme Disease Vaccine Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Veterinary Lyme Disease Vaccine Revenue Market Share by Region (2021–2032)
Figure 34. China Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 42. Latin America Veterinary Lyme Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Veterinary Lyme Disease Vaccine Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Veterinary Lyme Disease Vaccine Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Veterinary Lyme Disease Vaccine by Type (2021–2032)
Figure 53. Global Revenue Market Share of Veterinary Lyme Disease Vaccine by Type (2021–2032)
Figure 54. Global Veterinary Lyme Disease Vaccine Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Veterinary Lyme Disease Vaccine by Application (2021–2032)
Figure 56. Global Revenue Market Share of Veterinary Lyme Disease Vaccine by Application (2021–2032)
Figure 57. Global Veterinary Lyme Disease Vaccine Price (US$/Dose) by Application (2021–2032)
Figure 58. Veterinary Lyme Disease Vaccine Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
